Xiangqi Chen

1.4k total citations
60 papers, 946 citations indexed

About

Xiangqi Chen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiangqi Chen has authored 60 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiangqi Chen's work include Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer Mechanisms and Therapy (4 papers). Xiangqi Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer Mechanisms and Therapy (4 papers). Xiangqi Chen collaborates with scholars based in China, United States and South Africa. Xiangqi Chen's co-authors include Xiaoqiang Tang, Xiaofeng Chen, Sheng Yang, Yun Lei, Jinghua Chen, Yan An, Huanghao Yang, Jianming Lan, Juan Li and Liangliang Wang and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and Chemical Engineering Journal.

In The Last Decade

Xiangqi Chen

55 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangqi Chen China 17 513 173 136 117 88 60 946
Ming Zong China 19 392 0.8× 165 1.0× 119 0.9× 126 1.1× 140 1.6× 75 1.2k
Chunxi Wang China 18 558 1.1× 169 1.0× 141 1.0× 193 1.6× 88 1.0× 58 1.1k
Pingsheng Chen China 18 707 1.4× 373 2.2× 104 0.8× 120 1.0× 96 1.1× 48 1.2k
Can Chen China 21 552 1.1× 276 1.6× 172 1.3× 149 1.3× 136 1.5× 90 1.3k
Ke He China 18 403 0.8× 203 1.2× 134 1.0× 87 0.7× 68 0.8× 64 903
Qiang Tong China 19 554 1.1× 219 1.3× 182 1.3× 145 1.2× 112 1.3× 63 917
Bin Song China 18 454 0.9× 215 1.2× 165 1.2× 98 0.8× 66 0.8× 60 844
Hailun Zheng China 22 445 0.9× 236 1.4× 167 1.2× 93 0.8× 85 1.0× 54 903
Amir Avan Iran 18 348 0.7× 192 1.1× 166 1.2× 56 0.5× 71 0.8× 78 882

Countries citing papers authored by Xiangqi Chen

Since Specialization
Citations

This map shows the geographic impact of Xiangqi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangqi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangqi Chen more than expected).

Fields of papers citing papers by Xiangqi Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangqi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangqi Chen. The network helps show where Xiangqi Chen may publish in the future.

Co-authorship network of co-authors of Xiangqi Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangqi Chen. A scholar is included among the top collaborators of Xiangqi Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangqi Chen. Xiangqi Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiangqi, Shanshan Wang, Nan Zhang, et al.. (2025). Local therapy overcomes primary resistance to target-immunotherapy combination in unresectable hepatocellular carcinoma. Cancer Immunology Immunotherapy. 74(11). 331–331. 1 indexed citations
2.
Li, Fengquan, Yuan Liu, Dong Yan, et al.. (2025). Electronic modulation of PtCo catalysts by topological carbon defects boosting durable oxygen reduction reaction in acidic media. Fundamental Research. 1 indexed citations
3.
4.
Chen, Xiangqi, et al.. (2025). The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis. Advanced Science. 12(30). e05067–e05067.
5.
Luo, Qiong, et al.. (2024). Exosomes derived from gastric cancer cells promote phenotypic transformation of hepatic stellate cells and affect the malignant behavior of gastric cancer cells. Journal of Cancer Research and Therapeutics. 20(4). 1157–1164. 2 indexed citations
6.
Chen, Xiangqi, Xuerong Zheng, Yang Wang, et al.. (2024). Pre-adsorption of chlorine enhances the oxyphilic property and oxygen reduction activity of Fe/Se-NC electrocatalyst in seawater electrolyte. Chemical Engineering Journal. 482. 148856–148856. 13 indexed citations
7.
8.
Zhu, Changhua, et al.. (2024). The variant c.274A>G (p.Asn92Asp) in KRT17 in a patient with pachyonychia congenita and a novel clinical feature of acne inversa. Frontiers in Genetics. 15. 1365581–1365581. 1 indexed citations
9.
Chen, Xiangqi, Qian Liu, Zhiyuan Ma, et al.. (2023). The role of HMGB1 in digestive cancer. Biomedicine & Pharmacotherapy. 167. 115575–115575. 2 indexed citations
10.
Xun, Ziyu, et al.. (2023). Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade. Cancer Cell International. 23(1). 313–313. 13 indexed citations
11.
12.
Zhang, Ge, Bowen Chen, Xiaobo Yang, et al.. (2022). Prognostic analysis of patients with combined hepatocellular-cholangiocarcinoma after radical resection: A retrospective multicenter cohort study. World Journal of Gastroenterology. 28(41). 5968–5981. 8 indexed citations
13.
Lin, Lanlan, et al.. (2021). ARHGAP10 inhibits the epithelial–mesenchymal transition of non-small cell lung cancer by inactivating PI3K/Akt/GSK3β signaling pathway. Cancer Cell International. 21(1). 320–320. 10 indexed citations
14.
Lin, Lan, et al.. (2021). TTN/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients. Translational Cancer Research. 10(3). 1284–1294. 20 indexed citations
15.
Liu, Qing, et al.. (2020). Hyperprogressive disease in advanced cancer patients with liver metastasis treated with PD-1 inhibitors: two case reports. Annals of Translational Medicine. 8(17). 1100–1100. 2 indexed citations
16.
Chen, Xiangqi, et al.. (2019). Quantitative monitoring and mutations of ctDNA before and after non-small cell lung cancer radical surgery*. Oncology and Translational Medicine. 5(3). 103–108.
17.
Lin, Lanlan, Guofu Lin, Qiong Luo, & Xiangqi Chen. (2019). The incidence and relative risk of PD-1/PD-L1 inhibitors-related colitis in non-small cell lung cancer: A meta-analysis of randomized controlled trials. International Immunopharmacology. 77. 105975–105975. 5 indexed citations
18.
Xia, Yaokun, Liangliang Wang, Juan Li, et al.. (2018). A Ratiometric Fluorescent Bioprobe Based on Carbon Dots and Acridone Derivate for Signal Amplification Detection Exosomal microRNA. Analytical Chemistry. 90(15). 8969–8976. 161 indexed citations
19.
Fang, Jun, Lianglong Chen, Lin Fan, et al.. (2011). Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats. Journal of Molecular and Cellular Cardiology. 51(5). 839–847. 24 indexed citations
20.
Chen, Limin, Qing Liu, Zhenghui Huang, et al.. (2011). Tripchlorolide induces cell death in lung cancer cells by autophagy. International Journal of Oncology. 40(4). 1066–1070. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ming Zong Breakdown of academic impact, for papers by Chunxi Wang Breakdown of academic impact, for papers by Pingsheng Chen Breakdown of academic impact, for papers by Can Chen Breakdown of academic impact, for papers by Ke He Breakdown of academic impact, for papers by Qiang Tong Breakdown of academic impact, for papers by Bin Song Breakdown of academic impact, for papers by Hailun Zheng Breakdown of academic impact, for papers by Amir Avan
Rankless by CCL
2026